NEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Immunovant, Inc., (Nasdaq: IMVT) formerly known as Health Sciences Acquisitions Corporation (Nasdaq: HSAC) (“HSAC”), a special purpose acquisition company sponsored by RTW Investments, LP, announced today the closing of its business ...
NEW YORK, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Health Sciences Acquisitions Corporation ("HSAC," NASDAQ: HSAC), a special purpose acquisition company sponsored by RTW Investments, LP, announced today that it has set a record date and a meeting date for the special meeting of its stockholders t...
NEW YORK and LONDON , Oct. 8, 2019 /PRNewswire/ -- Health Sciences Acquisitions Corporation ("HSAC," NASDAQ: HSAC), a special purpose acquisition company sponsored by RTW Investments, and Immunovant Sciences Ltd. ("Immunovant"), a clinical-stage biopharmaceutical company focused on enab...
NEW YORK , Oct. 3, 2019 /PRNewswire/ -- Chardan, a global investment bank, announced today that the firm acted as M&A and Capital Markets Advisor for Health Sciences Acquisitions Corporation's (NASDAQ: HSAC) definitive share exchange agreement ("SEA") with Immunovant Sciences Ltd. ("I...
NEW YORK and LONDON , Oct. 2, 2019 /PRNewswire/ -- Health Sciences Acquisitions Corporation ("HSAC," NASDAQ: HSAC), a special purpose acquisition company sponsored by RTW Investments, and Immunovant Sciences Ltd. ("Immunovant"), a clinical-stage biopharmaceutical company focused on enab...
News, Short Squeeze, Breakout and More Instantly...
Health Sciences Acquisitions Corporation Company Name:
HSAC Stock Symbol:
NASDAQ Market:
NEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Immunovant, Inc., (Nasdaq: IMVT) formerly known as Health Sciences Acquisitions Corporation (Nasdaq: HSAC) (“HSAC”), a special purpose acquisition company sponsored by RTW Investments, LP, announced today the closing of its business ...
NEW YORK, Dec. 02, 2019 (GLOBE NEWSWIRE) -- Health Sciences Acquisitions Corporation ("HSAC," NASDAQ: HSAC), a special purpose acquisition company sponsored by RTW Investments, LP, announced today that it has set a record date and a meeting date for the special meeting of its stockholders t...
NEW YORK and LONDON , Oct. 8, 2019 /PRNewswire/ -- Health Sciences Acquisitions Corporation ("HSAC," NASDAQ: HSAC), a special purpose acquisition company sponsored by RTW Investments, and Immunovant Sciences Ltd. ("Immunovant"), a clinical-stage biopharmaceutical company focused on enab...